

Vericel Corporation (NASDAQ: VCEL) stock rose on Tuesday after announcing preliminary financial results for 2025.
You can purchase shares of Vericel (NASDAQ:VCEL) through any online brokerage.
Other companies in Vericel’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Vericel has a consensus price target of $61.71.
The stock price for Vericel (NASDAQ: VCEL) is $41.730545 last updated October 28, 2026 at 4:46 PM EDT.
There are no upcoming dividends for Vericel.
Vericel does not have any upcoming earnings scheduled.
There is no upcoming split for Vericel.
Vericel is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured...